Press Release

Immunomodulators Market to Exhibit 6.3% CAGR till 2027; Emergence of Laquinimod, Ozanimod, and Ponesimod to Bolster Growth

The global “immunomodulators market” is set to gain momentum from the increasing research activities to introduce unique approaches to treat cancer effectively. This information is published by Fortune Business Insights™ in a new study, titled, “Immunomodulators Market Size, Share & Industry Analysis, By Product Type (Immunosuppressant, Immunostimulants), By Application (Oncology, Respiratory, Multiple Sclerosis, and Others), and Regional Forecast, 2020-2027.” The study further mentions that the immunomodulators market size was USD 161.57 billion in 2019. It is projected to grow from USD 186.12 billion in 2020 to USD 285.01 billion in 2027 at a CAGR of 6.3% during the forecast period.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/sample/immunomodulators-market-104692

This report focuses on Immunomodulators Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

The COVID-19 pandemic has had a seismic effect on several economies across the globe. To curb the pandemic spread, the governments of several countries have ordered complete lockdown of industrial and human activities. This is expected to have a significant impact on the market in 2021. However, proactive steps by the industry leaders to revive the Healthcare industry will bode well for the growth of the market in the near future.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/immunomodulators-market-104692

Investment in Quality Control to Favor Growth amid COVID-19 Pandemic

The COVID-19 pandemic is set to affect the market for immunomodulators positively in the near future backed by the increasing sales of these products. Besides, numerous pharmaceutical companies are aiming to maintain the balance between demand and supply to keep their sales intact. They are also trying to invest more in quality control, refine their R&D activities, and enhance the supply chain management. We are offering in-depth analysis of the market to help you invest in the right zones.

Drivers & Restraints-

Rising Cases of Rheumatoid Arthritis to Accelerate Growth

The higher prevalence of multiple sclerosis is considered to be the second major cause of death, followed by cardiovascular disorders. The rising number of ongoing clinical trials to develop immunotherapeutic agents, namely, laquinimod, ozanimod, and ponesimod would propel the immunomodulators market in the upcoming years. Apart from that, the rising need to treat autoimmune disorders, such as rheumatoid arthritis is anticipated to spur demand. However, immunomodulators can cause severe infections including HIB, TB, fungal infections, hepatitis B, and hepatitis C viruses. These factors may hinder the demand for such drugs.

Segment-

Immunosuppressant Segment Held Highest Share Fueled by Rising Availability of Drugs

Based on the product type, the immunosuppressant segment held the majority of the immunomodulators market share in 2019. This growth is attributable to the usage of these drugs for treating autoimmune disorders, such as lupus and alopecia areata. Also, the presence of a wide range of these drugs capable of effectively treating the above-mentioned diseases would boost growth of the segment.

Quick Buy- Immunomodulators Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/104692

Competitive Landscape-

Key Players Focus on Introducing State-of-the-art Drugs to Gain a Competitive Edge

The global market for immunomodulators contains a large number of big, small, and medium companies. Most of them are striving persistently to gain a competitive edge in the market. To do so, they are coming up with novel immunomodulators to treat various chronic diseases. Below are the two latest industry developments:

  • October 2020: Cytocom, Inc. and Cleveland BioLabs, Inc. signed a merger agreement to blend their businesses in an individual transaction. This merger will transform the growth opportunity for Cleveland and Cytocom shareholders. It will also strengthen their positions and accelerate their potential to treat serious medical conditions with immune-modulating agents.
  • January 2020: Bristol Myers Squibb introduced its latest drug named Zeposia to treat multiple sclerosis. It can not only address less recognized cognitive issues but also the physical aspects of multiple sclerosis.

A list of all the reputed immunomodulators providers operating in the global market:

  • Hoffmann-La Roche Ltd (Basel, Switzerland)
  • Novartis AG (Basel, Switzerland)
  • Biogen (Massachusetts, U.S.)
  • Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel)
  • Amgen, Inc (California, U.S.)
  • Bristol-Myers & Squibb Company (New York, U.S)
  • Merck Sharp & Dohme Corp. (New jersey, U.S)
  • Eli Lilly and Company (Indiana, U.S)
  • Other Players

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immunomodulators-market-104692

Table of Content:

1 Immunomodulators Market Overview

1.1 Immunomodulators Product Overview

1.2 Immunomodulators Market Segment by Type

1.3 Global Immunomodulators Market Size by Type (2015-2027)

1.3.1 Global Immunomodulators Market Size Overview by Type (2015-2027)

1.3.2 Global Immunomodulators Historic Market Size Review by Type (2015-2021)

1.3.2.1 Global Immunomodulators Sales Market Share Breakdown by Type (2015-2027)

1.3.2.2 Global Immunomodulators Market Share Breakdown by Type (2015-2027)

1.3.2.3 Global Immunomodulators Average Selling Price (ASP) by Type (2015-2027)

1.3.3 Global Immunomodulators Market Size Forecast by Type (2021-2027)

1.3.3.1 Global Immunomodulators Sales Market Share Breakdown by Application (2021-2027)

1.3.3.2 Global Immunomodulators Revenue Market Share Breakdown by Application (2021-2027)

1.3.3.3 Global Immunomodulators Average Selling Price (ASP) by Application (2021-2027)

1.4 Key Regions Market Size Segment by Type (2015-2021)

1.4.1 North America Immunomodulators Sales Breakdown by Type (2015-2027)

1.4.2 Europe Immunomodulators Sales Breakdown by Type (2015-2027)

1.4.3 Asia-Pacific Immunomodulators Sales Breakdown by Type (2015-2027)

1.4.4 Latin America Immunomodulators Sales Breakdown by Type (2015-2027)

1.4.5 Middle East and Africa Immunomodulators Sales Breakdown by Type (2015-2027)

2 Global Immunomodulators Market Competition by Company

2.1 Global Top Players by Immunomodulators Sales (2015-2021)

2.2 Global Top Players by Immunomodulators Revenue (2015-2021)

2.3 Global Top Players Immunomodulators Average Selling Price (ASP) (2015-2021)

2.4 Global Top Company Immunomodulators Manufacturing Base Distribution, Sales Area, Product Type

2.5 Immunomodulators Market Competitive Situation and Trends

2.5.1 Immunomodulators Market Growth Rate (2015-2021)

2.5.2 Global 5 and 10 Largest Company by Immunomodulators Sales and Revenue in 2019

2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunomodulators as of 2019)

2.7 Date of Key Company Enter into Immunomodulators Market

2.8 Key Company Immunomodulators Product Offered

2.9 Mergers and Acquisitions, Expansion

3 Global Immunomodulators Status and Outlook by Region (2015-2027)

3.1 Global Immunomodulators Market Size and CAGR by Region: 2015 VS 2021 VS 2027

3.2 Global Immunomodulators Market Size Market Share by Region (2015-2021)

3.2.1 Global Immunomodulators Sales Market Share by Region (2015-2021)

3.2.2 Global Immunomodulators Revenue Market Share by Region (2015-2021)

3.2.3 Global Immunomodulators Sales, Revenue, Price and Gross Margin (2015-2021)

3.3 Global Immunomodulators Market Size Market Share by Region (2021-2027)

3.3.1 Global Immunomodulators Sales Market Share by Region (2021-2027)

3.3.2 Global Immunomodulators Revenue Market Share by Region (2021-2027)

3.3.3 Global Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2027)

3.4 North America Immunomodulators Market Size By Growth (2015-2027)

3.4.1 North America Immunomodulators Revenue By Growth (2015-2027)

3.4.2 North America Immunomodulators Sales By Growth (2015-2027)

3.5 Asia-Pacific Immunomodulators Market Size By Growth (2015-2027)

3.5.1 Asia-Pacific Immunomodulators Revenue By Growth (2015-2027)

3.5.2 Asia-Pacific Immunomodulators Sales By Growth (2015-2027)

3.6 Europe Immunomodulators Market Size By Growth (2015-2027)

3.6.1 Europe Immunomodulators Revenue By Growth (2015-2027)

3.6.2 Europe Immunomodulators Sales By Growth (2015-2027)

3.7 Latin America Immunomodulators Market Size By Growth (2015-2027)

3.7.1 Latin America Immunomodulators Revenue By Growth (2015-2027)

3.7.2 Latin America Immunomodulators Sales By Growth (2015-2027)

3.8 Middle East and Africa Immunomodulators Market Size By Growth (2015-2027)

3.8.1 Middle East and Africa Immunomodulators Revenue By Growth (2015-2027)

3.8.2 Middle East and Africa Immunomodulators Sales By Growth (2015-2027)

4 Global Immunomodulators by Application

4.1 Immunomodulators Segment by Application

4.1.1 Residential

4.1.2 Commercial

4.2 Global Immunomodulators Sales by Application: 2015 VS 2021 VS 2027

4.3 Global Immunomodulators Historic Sales by Application (2015-2021)

4.4 Global Immunomodulators Forecasted Sales by Application (2021-2027)

4.5 Key Regions Immunomodulators Market Size by Application

4.5.1 North America Immunomodulators by Application

4.5.2 Europe Immunomodulators by Application

4.5.3 Asia-Pacific Immunomodulators by Application

4.5.4 Latin America Immunomodulators by Application

4.5.5 Middle East and Africa Immunomodulators by Application

5 North America Immunomodulators Market Size by Country (2015-2027)

5.1 North America Market Size Market Share by Country (2015-2021)

5.1.1 North America Immunomodulators Sales Market Share by Country (2015-2021)

5.1.2 North America Immunomodulators Revenue Market Share by Country (2015-2021)

5.2 North America Market Size Market Share by Country (2021-2027)

5.2.1 North America Immunomodulators Sales Market Share by Country (2021-2027)

5.2.2 North America Immunomodulators Revenue Market Share by Country (2021-2027)

5.3 North America Market Size By Growth by Country

5.3.1 U.S. Immunomodulators Market Size By Growth (2015-2027)

5.3.2 Canada Immunomodulators Market Size By Growth (2015-2027)

6 Europe Immunomodulators Market Size by Country (2015-2027)

6.1 Europe Market Size Market Share by Country (2015-2021)

6.1.1 Europe Immunomodulators Sales Market Share by Country (2015-2021)

6.1.2 Europe Immunomodulators Revenue Market Share by Country (2015-2021)

6.2 Europe Market Size Market Share by Country (2021-2027)

6.2.1 Europe Immunomodulators Sales Market Share by Country (2021-2027)

6.2.2 Europe Immunomodulators Revenue Market Share by Country (2021-2027)

6.3 Europe Market Size By Growth by Country

6.3.1 Germany Immunomodulators Market Size By Growth (2015-2027)

6.3.2 France Immunomodulators Market Size By Growth (2015-2027)

6.3.3 U.K. Immunomodulators Market Size By Growth (2015-2027)

6.3.4 Italy Immunomodulators Market Size By Growth (2015-2027)

6.3.5 Russia Immunomodulators Market Size By Growth (2015-2027)

7 Asia-Pacific Immunomodulators Market Size by Country (2015-2027)

7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)

7.1.1 Asia-Pacific Immunomodulators Sales Market Share by Country (2015-2021)

7.1.2 Asia-Pacific Immunomodulators Revenue Market Share by Country (2015-2021)

7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)

7.2.1 Asia-Pacific Immunomodulators Sales Market Share by Country (2021-2027)

7.2.2 Asia-Pacific Immunomodulators Revenue Market Share by Country (2021-2027)

7.3 Asia-Pacific Market Size By Growth by Country

7.3.1 China Immunomodulators Market Size By Growth (2015-2027)

7.3.2 Japan Immunomodulators Market Size By Growth (2015-2027)

7.3.3 South Korea Immunomodulators Market Size By Growth (2015-2027)

7.3.4 India Immunomodulators Market Size By Growth (2015-2027)

7.3.5 Australia Immunomodulators Market Size By Growth (2015-2027)

7.3.6 Taiwan Immunomodulators Market Size By Growth (2015-2027)

7.3.7 Indonesia Immunomodulators Market Size By Growth (2015-2027)

7.3.8 Thailand Immunomodulators Market Size By Growth (2015-2027)

7.3.9 Malaysia Immunomodulators Market Size By Growth (2015-2027)

7.3.10 Philippines Immunomodulators Market Size By Growth (2015-2027)

ToC Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin | Twitter | BLogs

Related Reports :

Medical X-ray Market 

Central Nervous System Treatment Market 

Dental CAD/CAM Market 

Digestive Health Market 

Germany Hepatitis C Testing Market 

Immunomodulators Market 

Australia and New Zealand Prothrombin Complex Concentrate Market 

Computed Tomography Scanners Market 

Antibiotics Market 

Arthroscopy Fluid Management Disposables Market 

Video Laryngoscope Market 

Dermatology Drugs Market 

Medical X-ray Market Size

Central Nervous System Treatment Market Size

Dental CAD/CAM Market Size

Digestive Health Market Size

Germany Hepatitis C Testing Market Size

Immunomodulators Market Size

Australia and New Zealand Prothrombin Complex Concentrate Market Size

Computed Tomography Scanners Market Size

Antibiotics Market Size

Arthroscopy Fluid Management Disposables Market Size

Video Laryngoscope Market Size

Dermatology Drugs Market Size

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close